Premium
Ketoconazole treatment of nail infection in chronic mucocutaneous candidiasis
Author(s) -
ROBERTON D. M.,
HOSKING C. S.
Publication year - 1983
Publication title -
journal of paediatrics and child health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.631
H-Index - 76
eISSN - 1440-1754
pISSN - 1034-4810
DOI - 10.1111/j.1440-1754.1983.tb02088.x
Subject(s) - ketoconazole , medicine , chronic mucocutaneous candidiasis , mucocutaneous zone , nail (fastener) , dermatology , itraconazole , candida albicans , nail disease , mycosis , human immunodeficiency virus (hiv) , antifungal , immunology , microbiology and biotechnology , paronychia , disease , materials science , metallurgy , biology
. Chronic mucocutaneous candidiasis is an immunodeficiency disorder which has significant morbidity due to mucous membrane, skin and nail infection. Attempts at reconstitution of immunological abnormalities have had only limited success. Ketoconazole is a newly available oral antifungal agent with activity against candida species. Prolonged administration of ketoconazole to four children with chronic mucocutaneous candidiasis caused marked improvement at infected sites. Resolution of nail infections took up to 12 months.